Skip to content
White Paper

Producing Consistent, High Quality mAbs with Plants

iBio’s new paper, “Quality Plant-Made mAbs with FastPharming®,” illustrates FastPharming’s ability to manufacture consistent, high-quality antibodies.

Get the white paper:

stack of papers

The white paper explores the following benefits and more:

  • Plant-based mAbs are equivalent or superior in quality to CHO-derived antibodies
  • Glycaneering℠ allows tighter control of glycosylation for consistent homogeneous mAbs
  • iBio’s services include advanced bioanalytic capabilities
  • Development is faster with the avoidance of time-consuming cell line development
  • Bioreactor scale up issues are avoided by simply growing more plants
  • Reduced risk of contamination from mammalian viruses and prions